Uganda Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in uganda, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Healthcare
Last published date:

Overview

Uganda’s health system has both private and government funded facilities.  The government regulates operations of all healthcare facilities.  Private companies invest in hospitals, clinics, and pharmacies.  There is no national health insurance coverage, however there is private health insurance provided by insurance companies.  Health insurance coverage is low, estimated to be under 0.5% of GDP.  Several hospitals also run their own health insurance schemes.  Uganda’s medical facilities are attracting U.S. investors, especially in private medical care and oncology.  Health received 6% of the 2023/24 national budget, but donor funding comprises nearly 80% of resources.  Increasingly, the government is considering public-private-partnerships for healthcare investment, where government contributes land, and private investors build and operate a facility.  Uganda has 23 sites licensed for the manufacture of medicines and health supplies, although only 13 of these are involved in commercial production of pharmaceuticals.  The Uganda Virus Research Institute (UVRI), a government research institute, is a World Health Organization (WHO) certified yellow fever regional reference lab - the only certified yellow fever reference laboratory in Eastern Africa.  

Challenges to developing the sector include the following:

  • Technology, machinery, and the associated high-skilled expertise are sourced from outside Uganda.
  • Uganda’s pharmaceutical sector depends on importing active pharmaceutical ingredients and almost all excipients and some packaging materials.
  • Few Ugandan pharmaceutical manufacturers have automated production processes.
  • High operating costs for manufacturers relying on backup generators.
  • Few licensed cold and dry storage facilities to hold active pharmaceutical ingredients prior to final production.
  • Limited capacity and infrastructure for regulation and quality control. 

Opportunities

Equipment:  With Uganda’s lack of medical infrastructure and large influx of donor support for health programs, demand for medical equipment continues to rise.  Equipment in demand includes record management equipment and systems, ultrasound, electrocardiographs, obstetric dopplers, pulse oximeters, ventilators, cardiac echo machines, treadmill stress machines, and lab equipment (including equipment needed for microbiology, hematology, chemistry, and histopathology).

Generic pharmaceutical manufacturing:  Uganda still imports approximately 80% of its essential medicines and health supplies.  Based on Uganda’s strong demand for medical services and the government’s favorable tax policies for manufacturing facilities, manufacturing generic pharmaceuticals remains a profitable opportunity for investors.

Resources

Infectious Diseases Research Collaboration

Uganda Virus Research Institute

Joint Clinical Research Center

Makerere University College of Health Sciences

National Drug Authority

National Medical Stores

Uganda AIDS Commission

Uganda Ministry of Health

The Global Fund Pharmaceutical Sector Country Profile for Uganda

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility